BioSpace News Archive

Orexo AB (publ), the fully integrated specialty pharmaceutical company with the aim of becoming a leader within treatment of addiction, today announces it has acquired the exclusive US rights to vorvida®, a digital therapy for the treatment of Alcohol Use Disorder (AUD), from GAIA AG (GAIA), a global leader in digital therapeutics

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical, and Michael Vincent, Senior Vice President and Chief Scientific Officer, Inflammation and Immunology, at the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019 at 10:15 a.m. Eastern Standard Time..

AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, joins individuals and organizations around the world in recognition of World AIDS Day, December 1, 2019, an opportunity for people to unite in the fight against HIV, show support for people living with HIV and commemorate those who have died from an AIDS-related illness.

PAR, Inc. announced recently it has invested in local start-up Immertec, a company that applies virtual reality technology to medical and surgical training.

Access-Power, Inc. is in the final stages of a Corporate Action Request with a FINRA process whereby we earlier announced the merger with Grand Haven MM LLC.

Grant Will Support the Transfer of The Quilt, its Programs and a New Public Education Initiative to Reach Communities Adversely Impacted by HIV

Spherix Incorporated (Nasdaq: SPEX) announced today that additional patent coverage has been granted by the United States Patent & Trademark Office to the patent portfolio being acquired by Spherix, in the field of pancreatic cancer.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Fady I. Malik, M.D., Ph.D., Executive Vice President, Research & Development, is scheduled to participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 1:00 PM ET at the Lotte New York Palace Hotel in New York City.

Varian (NYSE: VAR) today announced Dr. Michelle Le Beau, professor of Medicine, University of Chicago and director, University of Chicago Medicine Comprehensive Cancer Center, has been appointed to the Varian Board of Directors, effective November 27, 2019.

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that company management will participate in two investor conferences in December.